Put The Spotlight On Your Company in the RESI Innovation Challenge

Every 90 days, RESI gathers hundreds of active early stage life science investors for a one-day partnering event. RESI Innovation Challenge finalists are provided with an all day showcase to attract the attention of those investors using their branding and messaging. It’s a unique opportunity to be a featured company in the life sciences industry. All applicants are vetted by LSN’s scientific review team, with a view to not just the quality of the company’s scientific work, but also the strength of the management team and how well-positioned the company is to receive investment.

What makes the RESI Innovation Challenge so valuable?  We’ve included a few words from previously successful participants below, but in short, being part of the Innovation Challenge provides startups with a new way to get attention and start dialogues with the investors who attend RESI.  Participants can share their message all day in the exhibit hall, with their Innovation Challenge display providing a starting point for a meaningful conversation about the opportunity.

Here is what our previous winners are saying about the RESI Innovation Challenge:

“I love the RESI Innovation Challenge because it is a great way to give our pitch to practice it and try to obtain a scarce resource from these investors. Practicing with these investors is a great way to build relationships and continue that on to the real investment conversations.”

– Niko Skievaski, Co-Founder, Redox

1st Place, RESI@TMCx, June 8, 2015

“The RESI Innovation Challenge is a really good opportunity to meet investors and other companies in the space.  It’s a good showcase to reach that audience.”

– Jessica Ching, CEO, Eve Medical

2nd Place, RESI San Francisco, January 12, 2016

“The RESI Innovation Challenge is a unique way to pitch, and provides a great opportunity to see what other companies are doing in the industry, while allowing you to meet with potential investors and strategic partners outside of the partnering meetings.”

– John Connolly, VP Corporate Development, Rna Diagnostics

1st Place, RESI Boston, September 16, 2015

“RESI offers small companies like GeneSegues a direct line to potential partners and potential investors in a small setting conducive to relationship building and conversation. The Innovation Challenge was a particularly great way to introduce our company to a broader audience than I could meet with personally which allowed us to leverage the showcasing of our technology more efficiently.”

-Laura M. Brod，Chief Executive Officer，GeneSegues Therapeutics

-1st Place, RESI @TMCx, April 11, 2016

Laura Brod, CEO, GeneSegues

Austin Dirks, CEO & CO-Founder, GreenLight Medical

Alexander Schüller, President, Adhesys

Shravanthi Reddy, COO, ClearSight

Jessica Ching, CEO, Eve Medical

Jonathan W. Gunn, JD, PhD, CEO & Co-founder

RESI Boston September 16, 2015

1st Place

Jonathan W. Gunn, JD, PhD, CEO & Co-founder, Rna Diagnostics

2nd Place

Matthew R. Gevaert, Ph.D. CEO & Co-founder

3rd Place

Kenneth J. Slepicka, CEO & Director

RESI@TMCx June 8, 2015

1st Place

Niko Skievaski, Co-founder, Redox

2nd Place

Wade Lange, CEO, NeuroFx

3rd Place

Laura Bosworth, CEO & co-founder, TeVido BioDevices

RESI San Francisco January 13, 2015

1st Place

Shawn Iadonato, Ph.D., CEO, Kineta

2nd Place

Eric Goslau, CEO, Transverse Medical

3rd Place

Robert Thompson, President & CEO, Amorphex Therapeutics

RESI Boston September 17, 2014

1st Place

Robin Smith, CEO, ORIG3N

2nd Place

Jeff Missling, CEO, SpineThera

3rd Place

Kurt Dieck, President & CEO, Biosortia

RESI Boston March 24, 2014

1st Place

Pam Randhawa, Founder & CEO, EMPIRIKO

2nd Place

Marcia Fournier, CEO, BIOARRAY

3rd Place

Magdalena Leszczyniecka, President & CEO, STC Biologics Tasos Smeros, Founder & CEO, Multineurons

Apply today for the chance to join!

Tags: Innovator's Pitch Challenge, RESI